Sexuality and the menopause

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 23, Issue 1, 2009, Pages 33-52

  Pitkin, Joan ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

ageing; female sexual dysfunction; hormones; menopause; new models of sexual response; oestrogen; premature menopause; sexual function; sexual response; sexuality; testosterone

Indexed keywords

DROSPIRENONE PLUS ESTRADIOL; ESTRADIOL; ESTROGEN; METHYLTESTOSTERONE; PLACEBO; SEX HORMONE; SILDENAFIL; TESTOSTERONE; TESTOSTERONE UNDECANOATE; TIBOLONE;

BIOASSAY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; ETHNIC GROUP; FEMALE SEXUAL DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; LONGITUDINAL STUDY; MENOPAUSE; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUALITY;

ADULT; AGED; AGING; CROSS-SECTIONAL STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIBIDO; MENOPAUSE; MIDDLE AGED; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; WOMEN'S HEALTH;

EID: 58249129323     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2008.10.011     Document Type: Review

References (163)

1. Lock M. Menopause in cultural context. Exp Gerontol 29 (1994) 307-317
2. Dennerstein L., Alexander J.L., and Kotz K. The menopause and sexual functioning: a review of the population-based studies. Annu Rev Sex Res 14 (2003) 64-82
3. Sampselle C.M., Harris V., Harlow S.D., et al. Midlife development and menopause in African American and Caucasian women. Health Care Women Int 23 (2002) 351-363
4. Rubin L.B. Women of a certain age: the midlife search for self. HarperCollins Publishers (1979)
5. Jaszman L., Van Lith N.D., and Zaat J.C.A. The perimenopausal symptoms: the statistical analysis of a survey. Med Gynaecol Sociol 4 (1969) 268-277
6. Laumann E.O., Paik A., and Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999) 537-544
7. Dennerstein L., Randolph J., Taffe J., et al. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 77 Suppl. 4 (2002) S42-S48
8. Healthy Sexuality and Vital Aging. A Study by the National Council on the Aging Survey. Conducted by Roper Starch. Available from: (1998). www.ncoa.org
9. Jacoby S. Great Sex, Modern Maturity. Special Report: the 1999 AARP/Modern Maturity Survey on Sexual Attitudes and Behaviour. 1999.
10. Hartmann U., Philippsohn S., Heiser K., et al. Low sexual desire in midlife and older women: personality factors, psychosocial development, present sexuality. Menopause 11 (2004) 726-740
11. Johnson A.M., Mercer C.H., Erens B., et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 358 (2001) 1835-1842
12. Erens B., McManus S., Field J., et al. National survey of sexual attitudes and lifestyles II: technical report (2001), Natcen, University College London, London
13. Mercer C.H., Fenton K.A., Johnson A.M., et al. Sexual function problems and help seeking behaviour in Britain: national probability sample survey. BMJ 327 (2003) 426-427
14. Frank E., Anderson C., and Rubinstein D. Frequency of sexual dysfunction in "normal" couples. N Engl J Med 299 (1978) 111-115
15. Rosen R.C., Taylor J.F., Leiblum S.R., et al. Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynaecological clinic. J Sex Marital Ther 19 (1993) 171-188
16. Spector I.P., and Carey M.P. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 19 (1990) 389-408
17. Laumann E.O., Paik A., and Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999) 537-544 Erratum in: JAMA 1999; 281: 1174
18. Dennerstein L., and Lehert P. Women's sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause 11 (2004) 778-785
19. Dennerstein L., Lehert P., and Dudley E. Short scale to measure female sexuality: adapted from McCoy female sexuality questionnaire. J Sex Marital Ther 27 (2001) 339-351
20. Nappi R.E., and Nijland E.A. Women's perception of sexuality around the menopause: outcomes of a European telephone survey. Eur J Obstet Gynecol Reprod Biol 137 (2008) 10-16
21. Meston C.M., Trapnell P.D., and Gorzalka B.B. Ethnic, gender, and length of residency influences on sexual knowledge and attitudes. J Sex Res 35 (1998) 176-188
22. Hayes R., and Dennerstein L. The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies. J Sex Med 2 (2005) 317-330
23. Laumann E.O., Gagnon J.H., Michael R.T., et al. The social organization of sexuality: sexual practices in the United States (1994), University of Chicago Press, Chicago
24. Dennerstein L., and Lehert P. Modeling mid-aged women's sexual functioning: a prospective, population-based study. J Sex Marital Ther 30 (2004) 173-183
25. Basson R., Berman J., Burnett A., et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163 (2000) 888-893
26. Johnson S.D., Phelps D.L., and Cottler L.B. The association of sexual dysfunction and substance use among a community epidemiological sample. Arch Sex Behav 33 (2004) 55-63
27. Cain V.S., Johannes C.B., Avis N.E., et al. Sexual functioning and practices in a multi-ethnic study of midlife women: baseline results from SWAN. J Sex Res 40 (2003) 266-276
28. Barlow D.H., Cardozo L.D., Francis R.M., et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 104 (1997) 87-91
29. Fugl-Meyer K. Women's sexual dysfunctions and dysfunctional distress: a Swedish report (2003), ISSWSH, Amsterdam
30. Bergstrom-Walan M., and Neilsen H. Fertility and sterility: sexual expression among 60-80 year old men and women: a sample from Stockholm, Sweden. J Sex Res 27 (1990) 289-295
31. Bretschneider J.G., and McCoy N.L. Sexual interest and behavior in healthy 80- to 102-year-olds. Arch Sex Behav 17 (1988) 109-129
32. Dennerstein L., Lehert P., Burger H., et al. Sexuality. Am J Med 118 Suppl. 12B (2005) 59-63
33. Guthrie J.R., Dennerstein L., Taffe J.R., et al. Health care-seeking for menopausal problems. Climacteric 6 (2003) 112-117
34. Lunde I., Larson G.K., Fog E., et al. Sexual desire, orgasm, and sexual fantasies: a study of 625 Danish women born in 1910, 1936 and 1958. J Sex Educ Ther 17 (1991) 111-115
35. Bancroft J., Loftus J., and Long J.S. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav 32 (2003) 193-208
36. Hällström T. Sexuality in the climacteric. Clin Obstet Gynaecol 4 (1977) 227-239
37. Fugl-Meyer A.R., and Fugl-Meyer K. Sexual disabilities, problems and satisfaction in 18-74 yr old Swedes. Scand J Sexol 2 (1999) 79-105
38. Rissel C.E., Richters J., Grulich A.E., et al. Sex in Australia: selected characteristics of regular sexual relationships. Aust N Z J Public Health 27 (2003) 124-130
39. Richters J., Grulich A.E., de Visser R.O., et al. Sex in Australia: autoerotic, esoteric and other sexual practices engaged in by a representative sample of adults. Aust N Z J Public Health 27 (2003) 180-190
40. Gracia C.R., Sammel M.D., Freeman E.W., et al. Predictors of decreased libido in women during the late reproductive years. Menopause 11 (2004) 144-150
41. Ventegodt S. Sex and the quality of life in Denmark. Arch Sex Behav 27 (1998) 295-307
42. Kadri N., McHichi Alami K.H., and McHakra Tahiri S. Sexual dysfunction in women: population based epidemiological study. Arch Womens Ment Health 5 (2002) 59-63
43. Najman J.M., Dunne M.P., Boyle F.M., et al. Sexual dysfunction in the Australian population. Aust Fam Physician 32 (2003) 951-954
44. Hällström T., and Samuelsson S. Changes in women's sexual desire in middle life: the Longitudinal Study of Women in Gothenburg. Arch Sex Behav 19 (1990) 259-268
45. Køster A., and Garde K. Sexual desire and menopausal development. A prospective study of Danish women born in 1936. Maturitas 16 (1993) 49-60
46. Dennerstein L., Anderson-Hunt M., and Dudley E. Evaluation of a short scale to assess female sexual functioning. J Sex Marital Ther 28 (2002) 389-397
47. McCoy N.L., and Matyas J.R. Oral contraceptives and sexuality in university women. Arch Sex Behav 25 (1996) 73-90
48. Dennerstein L., Lehert P., and Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 84 (2005) 174-180
49. Kinsey A.C., Pomeroy W.B., et al. Sexual behavior in the human female (1953), WB Saunders, New York
50. Newman G., and Nichols C.R. Sexual activites and attidues in older persons. JAMA 173 (1960) 33-35
51. Mansfield P.K., Voda A., and Koch P.B. Predictors of sexual response changes in heterosexual midlife women. J Health Values (1995)
52. Deeks A.A., and McCabe M.P. Sexual function and the menopausal woman: the importance of age and partner's sexual functioning. J Sex Res 38 (2001) 219-225
53. Fugl-Meyer K., and Fugl-Meyer A.R. Sexual disabilities are not singularities. Int J Impot Res 14 (2002) 487-493
54. Kontula O., and Haavio-Mannila E. Sexual pleasures: enhancement of sex life in Finland, 1971-1992. Dartmouth (1995) 287s
55. Blümel J.E., Castelo-Branco C., Cancelo M.J., et al. Impairment of sexual activity in middle-aged women in Chile. Menopause 11 (2004) 78-81
56. Dennerstein L., Smith A.M., Morse C.A., et al. Sexuality and the menopause. J Psychosom Obstet Gynaecol 15 (1994) 59-66
57. Derogatis L.R., Rosen R., Leiblum S., et al. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 28 (2002) 317-330
58. James W.H. Decline in coital rates with spouses' ages and duration of marriage. J Biosoc Sci 15 (1983) 83-87
59. Hawton K., Gath D., and Day A. Sexual function in a community sample of middle-aged women with partners: effects of age, marital, socioeconomic, psychiatric, gynecological, and menopausal factors. Arch Sex Behav 23 (1994) 375-395
60. Dennerstein L., Lehert P., Burger H., et al. Factors affecting sexual functioning of women in the mid-life years. Climacteric 2 (1999) 254-262
61. Pfeiffer E., Verwoerdt A., and Davis G.C. Sexual behavior in middle life. Am J Psychiatry 128 (1972) 1262-1267
62. Dennerstein L., Koochaki P., Barton I., et al. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 3 (2006) 212-222
63. Leiblum S.R., Koochaki P.E., Rodenberg C.A., et al. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 13 (2006) 46-56
64. Bachmann G.A., and Leiblum S.R. The impact of hormones on menopausal sexuality: a literature review. Menopause 11 (2004) 120-130
65. Berman J.R., Berman L., and Goldstein I. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology 54 (1999) 385-391
66. Laan E., van Driel E., and van Lunsen R.H.W. Sexual responses of women with sexual arousal disorder to visual sexual stimuli. Tijdschr Seksuol 27 (2003) 1-13
67. Levin R.J. The mechanisms of human female sexual arousal. Ann Rev Sex Res 3 (1992) 1-48
68. Sarrel P.M., and Wiita B. Vasodilator effects of estrogen are not diminished by androgen in postmenopausal women. Fertil Steril 68 (1997) 1125-1127
69. Park K., Ahn K., Lee S., et al. Decreased circulating levels of estrogen alter vaginal and clitoral blood flow and structure in the rabbit. Int J Impot Res 13 (2001) 116-124
70. Min K., Munarriz R., Kim N.N., et al. Effects of ovariectomy and estrogen and androgen treatment on sildenafil-mediated changes in female genital blood flow and vaginal lubrication in the animal model. Am J Obstet Gynecol 187 (2002) 1370-1376
71. Wagner G., and Levin R.J. Electrolytes in vaginal fluid during the menstrual cycle of coitally active and inactive women. J Reprod Fertil 60 (1980) 17-27
72. Laan E., Everaerd W., and Evers A. Assessment of female sexual arousal: response specificity and construct validity. Psychophysiology 32 (1995) 476-485
73. Laan E., and Everaerd W. Physiological measures of vaginal vasocongestion. Int J Impot Res 10 Suppl. 2 (1998) S107-S110
74. Levin R.J. Assessing human female sexual arousal by vaginal photoplethysmograph: a critical examination. Sexologies (Eur J Med Sex) 6 (1997) 25-31
75. Wouda J.C., Hartman P.M., Bakker R.M., et al. Vaginal plethysmography in women with dyspareunia. J Sex Res 35 (1998) 141-147
76. Wincze J.P., Hoon E.F., and Hoon P.W. Physiological responsivity of normal and sexually dysfunctional women during erotic stimulus exposure. J Psychosom Res 20 (1976) 445-451
77. Wincze J.P., Hoon E.F., and Hoon P.W. Multiple measure analysis of women experiencing low sexual arousal. Behav Res Ther 16 (1978) 43-49
78. Palace E.M. Modification of dysfunctional patterns of sexual response through autonomic arousal and false physiological feedback. J Consult Clin Psychol 63 (1995) 604-615
79. Meston C.M., and Gorzalka B.B. Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women. J Abnorm Psychol 105 (1996) 582-591
80. Morokoff P.J., and Heiman J.R. Effects of erotic stimuli on sexually functional and dysfunctional women: multiple measures before and after sex therapy. Behav Res Ther 18 (1980) 127-137
81. Laan E., and van Lunsen R.H. Hormones and sexuality in postmenopausal women: a psychophysiological study. J Psychosom Obstet Gynaecol 18 (1997) 126-133
82. Burger H.G., Dudley E.C., Hopper J.L., et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 84 (1999) 4025-4030
83. Laughlin G.A., Barrett-Connor E., Kritz-Silverstein D., et al. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85 (2000) 645-651
84. Judd H.L., Judd G.E., Lucas W.E., et al. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 39 (1974) 1020-1024
85. Rhodes J.C., Kjerulff K.H., Langenberg P.W., et al. Hysterectomy and sexual functioning. JAMA 282 (1999) 1934-1941
86. Nathorst-Böös J., and von Schoultz B. Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest 34 (1992) 97-101
87. Nathorst-Böös J., von Schoultz B., and Carlström K. Elective ovarian removal and estrogen replacement therapy - effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 14 (1993) 283-293
88. Dennerstein L., Wood C., and Burrows G.D. Sexual response following hysterectomy and oophorectomy. Obstet Gynecol 49 (1977) 92-96
89. Davison S.L., Bell R., Donath S., et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90 (2005) 3847-3853
90. Nathorst-Böös J., Jarkander-Rolff M., Carlström K., et al. Percutaneous administration of testosterone gel in postmenopausal women - a pharmacological study. Gynecol Endocrinol 20 (2005) 243-248
91. Burger H.G., Dudley E.C., Cui J., et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85 (2000) 2832-2838
92. Sowers M.R., Jannausch M., Randolph J.F., et al. Androgens are associated with hemostatic and inflammatory factors among women at the mid-life. J Clin Endocrinol Metab 90 (2005) 6064-6071
93. Ausmanas M.K., Tan D.A., Jaisamrarn U., et al. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study. Climacteric 10 (2007) 427-437
94. Obel E.B., Munk-Jensen N., Svenstrup B., et al. A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment. Maturitas 16 (1993) 13-21
95. Davison S.L., Bell R., Montalto J.G., et al. Measurement of total testosterone in women: comparison of a direct radio-immunoassay versus radioimmunoassay after organic solvent extraction and celite column partition chromatography. Fertil Steril 84 (2005) 1698-1704
96. Bell R.J., Donath S., Davison S.L., et al. Endogenous androgen levels and well-being: differences between pre-menopausal and postmenopausal women. Menopause 13 (2006) 65-71
97. Davis S.R., Davison S.L., Donath S., et al. Circulating androgen levels and self-reported sexual function in women. JAMA 294 (2005) 91-96
98. Nappi R.E. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis. Climacteric 10 Suppl. 2 (2007) 105-108
99. Basson R. Introduction to special issue on women's sexuality and outline of assessment of sexual problems. Menopause 11 (2004) 709-713
100. Wylie K.R. Sexuality and the menopause. J Br Menopause Soc 12 (2006) 149-152
101. McCoy N.L. The McCoy Female Sexuality Questionnaire Source. Qual Life Res 9 Suppl. 1 (2000) 739-745
102. Rosen R.C., Lobo R.A., Block B.A., et al. Menopausal Sexual Interest Questionnaire (MSIQ): a unidimensional scale for the assessment of sexual interest in postmenopausal women. J Sex Marital Ther 30 (2004) 235-250
103. Utian W.H., MacLean D.B., Symonds T., et al. A methodology study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women. J Sex Marital Ther 31 (2005) 271-283
104. Wiegel M., Meston C., and Rosen R. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31 (2005) 1-20
105. McHorney C.A., Rust J., Golombok S., et al. Profile of female sexual function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women. Menopause 11 (2004) 474-483
106. Masters W.H., and Johnson V.E. The human sexual response (1966), Littlebrown & Co, Boston
107. Kaplan H.S. Hypoactive sexual desire. J Sex Marital Ther 3 (1977) 3-9
108. Basson R. Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 98 (2001) 350-353
109. Basson R. Female sexual response: revisited. J Soc Obstet Gynecol (2000) 378-383
110. Laan E., Everaerd W., van der Velde J., et al. Determinants of subjective experience of sexual arousal in women: feedback from genital arousal and erotic stimulus content. Psychophysiology 32 (1995) 444-451
111. Levine S. Intrapsychic and individual aspects of sexual desire. In: Lieblum S.R., and Rosen R.C. (Eds) (1988), Guilford Press, New York 21-44
112. Hatfield E., and Rapson R.L. Love, sex, and intimacy: their psychology, biology, and history (1993), HarperCollins Publishers, New York
113. Bachmann G., Bancroft J., Braunstein G., et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 77 (2002) 660-665
114. Basson R., Leiblum S., Brotto L., et al. Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol 24 (2003) 221-229
115. American Psychiatric Association. (DSM-IV-TR) Diagnostic and statistical manual of mental disorders. 4th edn. (2000), American Psychiatric Press, Washington DC
116. World Health Organization. ICD-10; International statistical classification of diseases and related health problems (1992), World Health Organization, Geneva
117. Nappi R.E., Wawra K., and Schmitt S. Hypoactive sexual desire disorder in postmenopausal women. Gynecol Endocrinol 22 (2006) 318-323
118. Pitkin J., Rees M.P., Gray S., et al., Writing Group for the British Menopause Society Council. British Menopause Society Council consensus statement on hormone replacement therapy. Menopause Int (2008)
119. Pines A, Sturdee DW, Birkhäuser MH, et-al. Board of the International Menopause Society.HRT in the early menopause: scientific evidence and common perceptions. Summary of the First IMS Global Summit on Menopause-related Issues, March 29-30 2008.
120. Suckling J., Lethaby A., and Kennedy R. Local estrogen for vaginal atrophy in post-menopausal women. Cochrane Database Syst Rev (2006) 4
121. Cardozo L., Bachmann G., McClish D., et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 92 (1998) 722-727
122. Kloosterboer H.J. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 76 (2001) 231-238
123. Timmer C.J., and Houwing N.S. Dose proportionality of three different doses of tibolone. Pharmacotherapy 22 (2002) 106-113
124. Falany J.L., Macrina N., and Falany C.N. Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 88 (2004) 383-391
125. Hofling M., Carlström K., Svane G., et al. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels - an association with mammographic density. Gynecol Endocrinol 20 (2005) 110-115
126. Dören M., Rübig A., Coelingh Bennink H.J., et al. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril 75 (2001) 554-559
127. Landgren M.B., Helmond F.A., and Engelen S. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day. Maturitas 50 (2005) 222-230
128. Genazzani A.R., Petraglia F., Facchinetti F., et al. Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and post-menopausal women. Maturitas Suppl. 1 (1987) 35-48
129. Modelska K., and Cummings S. Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials. Am J Obstet Gynecol 188 (2003) 286-293
130. Basson R., McInnes R., Smith M.D., et al. Efficacy and safety of sildenafil in estrogenised women with sexual dysfunction associated with female sexual arousal disorder. Obstet Gynecol 95 (2000) S1-S54
131. Sherwin B.B. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72 (1991) 336-343
132. Sarrel P., Dobay B., and Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 43 (1998) 847-856
133. Nevinny-Stickel J. Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients. Arch Gynecol 234 (1983) 27-31
134. Laan E., van Lunsen R.H., and Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 4 (2001) 28-41
135. Nathorst-Böös J., and Hammar M. Effect on sexual life - a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. Maturitas 26 (1997) 15-20
136. Castelo-Branco C., Vicente J.J., Figueras F., et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 34 (2000) 161-168
137. Osmanagaoglu M.A., Atasaral T., Baltaci D., et al. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women. Climacteric 9 (2006) 464-472
138. Uygur D., Yesildaglar N., and Erkaya S. Effect on sexual life - a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate. Gynecol Endocrinol 20 (2005) 209-212
139. Morris E.P., Wilson P.O., Robinson J., et al. Long term effects of tibolone on the genital tract in postmenopausal women. Br J Obstet Gynaecol 106 (1999) 954-959
140. Cayan F., Dilek U., Pata O., et al. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women. J Sex Med 5 (2008) 132-138
141. Somboonporn W., Davis S., Seif M.W., et al. Testosterone for peri- and post-menopausal women. Cochrane Database Syst Rev 4 (2005) CD004509
142. Barrett-Connor E., Young R., Notelovitz M., et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 44 (1999) 1012-1020
143. Luciano AA, Miller BE, Sequenzia L, et al. The effect of sublingual micronized estradiol progesterone and testosterone on menopausal symptoms in sexual health. 9th International Menopause Society World Congress on the Menopause, Yokohama, Japan, 1999.
144. Flöter A., Nathorst-Böös J., Carlström K., et al. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 5 (2002) 357-365
145. Regestein Q.R., Friebely J., Shifren J., et al. Neuropsychological effects of methyl- testosterone in women using menopausal hormone replacement. J Womens Health Gend Based Med 10 (2001) 671-676
146. Sherwin B.B. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 14 (1988) 177-187
147. Shifren J.L., Braunstein G.D., Simon J.A., et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343 (2000) 682-688
148. Burger H., Hailes J., Nelson J., et al. Effect of combined implants of estradiol and testosterone on libido in postmenopausal women. BMJ (Clin Res Ed) 294 (1987) 936-937
149. Davis S.R., McCloud P., Strauss B.J., et al. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21 (1995) 227-236
150. Dow M.G., Hart D.M., and Forrest C.A. Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. Br J Obstet Gynaecol 90 (1983) 361-366
151. Penotti M., Sironi L., Cannata L., et al. Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries. Fertil Steril 76 (2001) 235-240
152. Braunstein GD, Shifren JL, Simon JA, et al. Testosterone patches for the treatment of low sexual desire in surgically menopausal women. NAMS, 14th Annual Meeting, Florida, USA, 2003.
153. Davis S, Lucas J, Moufarege A, et al. Testosterone patches for the treatment of low sexual desire in surgically menopausal women. 7th Australian Menopause Society Congress, Tasmania, Australia, 2003.
154. Lobo R.A., Rosen R.C., Yang H.M., et al. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 79 (2003) 1341-1352
155. Dobs A.S., Nguyen T., Pace C., et al. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 87 (2002) 1509-1516
156. Sherwin B.B., Gelfand M.M., and Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 47 (1985) 339-351
157. Alexander J.L., Dennerstein L.J., Berger H., et al. Testosterone and libido in surgically and naturally menopausal women. Womens Health 2 (2006) 459-477
158. Buster J.E., Kingsberg S.A., Aguirre O., et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 105 (2005) 944-952
159. Simon J., Braunstein G., Nachtigall L., et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90 (2005) 5226-5233
160. Kingsberg S. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. J Sex Med 4 Suppl. 3 (2007) 227-234
161. Derogatis L. Some thoughts on integrating sexual desire and motivation. White paper submitted to the Working Group on Womens Sexual Desire and Arousal Disorders, 2002.
162. Nachtigall L, Casson P, Lucas J, et-al. Safety and tolerability of transdermal testosterone system (TTS) in surgically menopausal women receiving oral or transdermally estrogen over 36 months of therapy. The North American Menopause Society 17th Annual Meeting, 2006.
163. Shifren J.L., Davis S.R., Moreau M., et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 13 (2006) 770-779 Erratum in: Menopause 2007; 14: 157